Medicine and Dentistry
Tick Borne Encephalitis
100%
Apoplexy
33%
Infection
29%
Brain Ischemia
28%
Tick Borne Encephalitis Virus
25%
Disease
23%
Cerebral Hemorrhage
18%
Magnetic Resonance Imaging
17%
Tick Borne Encephalitis Vaccine
17%
Headache
16%
Observational Study
15%
Cerebrovascular Disease
15%
Clinical Feature
14%
Mild Cognitive Impairment
14%
Transient Ischemic Attack
14%
Myasthenia gravis
14%
Odds Ratio
14%
Epileptic Seizure
13%
Cross Sectional Study
12%
Enzyme Linked Immunosorbent Assay
11%
Central Nervous System
11%
Multiple Sclerosis
11%
Lyme Borreliosis
10%
Polyneuropathy
9%
Human Herpesvirus 7
9%
Cohort Effect
9%
National Institutes of Health Stroke Scale
8%
Bulbar Palsy
8%
Tick-Borne Disease
8%
Population
8%
Consultation
8%
Patient with Epilepsy
7%
Tick Bite
7%
Neurologic Disease
7%
COVID-19
7%
Alcoholic Polyneuropathy
7%
HLA-DRB1
7%
Ankylosing Spondylitis
7%
Brain Disease
7%
Fatality
7%
Rituximab
7%
Perivascular Space
7%
Posterior Reversible Encephalopathy Syndrome
7%
ECG Abnormality
7%
Scleroderma
7%
Caprylic Acid
7%
Sequela
7%
Acute Intermittent Porphyria
7%
Brain Hematoma
7%
Troponin T
7%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Ischemia
45%
Tick Borne Encephalitis
44%
Cerebrovascular Accident
30%
Multiple Sclerosis
29%
Transient Ischemic Attack
22%
Brain Hemorrhage
19%
Infection
17%
Fibrinolytic Agent
15%
Mortality Rate
12%
Human Herpesvirus 7
11%
Tick Borne Encephalitis Virus
10%
Placebo
10%
Tick Borne Encephalitis Vaccine
10%
Enzyme-Linked Immunosorbent Assay
9%
Ethanol
8%
Atrial Fibrillation
7%
Myasthenia gravis
7%
Human Immunoglobulin
7%
Idarucizumab
7%
Antithrombotic Therapy
7%
ECG Abnormality
7%
Sudden Death
7%
Observational Study
7%
Carbidopa Plus Levodopa
7%
Dabigatran
7%
Siponimod
7%
Ofatumumab
7%
Brain Hematoma
7%
Troponin T
7%
Gadolinium
7%
Syndrome
7%
Immunotherapy
7%
Parkinson's Disease
7%
Cross Sectional Study
7%
Ankylosing Spondylitis
7%
Clinical Feature
7%
Tenecteplase
7%
Human Herpesvirus 6
7%
Heart Left Ventricle Hypertrophy
7%
Octanoic Acid
7%
Disease
6%
Anticoagulant Agent
5%
Adverse Event
5%
Neuroscience
Mild Cognitive Impairment
42%
Cognitive Disorders
41%
Multiple Sclerosis
21%
Cerebrovascular Accident
19%
Encephalitis
16%
Magnetic Resonance Imaging
16%
Montreal Cognitive Assessment
16%
Brain Ischemia
15%
Headache
14%
Transient Ischemic Attack
14%
Magnetic Resonance Imaging
10%
Blood Plasma
9%
Human Herpesvirus 7
9%
Cerebral Hemorrhage
9%
Rituximab
8%
Placebo
8%
Magnetic Resonance Imaging of Brain
7%
Cerebellar Cortex
7%
Severe Depression
7%
Brodmann Area
7%
Hamilton Rating Scale for Depression
7%
Fractional Anisotropy
7%
Teriflunomide
7%
Automutilation
7%
Ofatumumab
7%
Corpus Callosum
7%
Cerebellum
7%
Alzheimer's Disease
7%
Alcohol Abuse
7%
Neuromyelitis Optica
7%
Tenecteplase
7%
Secondary Progressive Multiple Sclerosis
7%
Lyme Disease
7%
Parkinson's Disease
7%
Randomized Controlled Trial
7%
QT Interval
7%
Left Ventricular Hypertrophy
7%
Brain Disease
7%
Human Herpesvirus 6
7%
Roseolovirus
7%
Expanded Disability Status Scale
7%
Diffusion Tensor Imaging
6%
Intravenous Immunoglobulin
6%
Entorhinal Cortex
5%